1	Membrane-associated	membrane-associated	_	_	_	_	_	_	_
2	lymphotoxin	lymphotoxin	_	_	_	_	_	_	_
3	on	on	_	_	_	_	_	_	_
4	natural	natural	_	_	_	_	_	_	_
5	killer	killer	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	activates	activate	_	_	_	_	_	_	_
8	endothelial	endothelial	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	via	via	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	NF-kappaB-dependent	nf-kappab-dependent	_	_	_	_	_	_	_
13	pathway	pathway	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Inhibition	Inhibition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	complement	complement	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	small	small	_	_	_	_	_	_	_
8	animal	animal	_	_	_	_	_	_	_
9	models	model	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	xenotransplantation	xenotransplantation	_	_	_	_	_	_	_
12	has	have	_	_	_	_	_	_	_
13	demonstrated	demonstrate	_	_	_	_	_	_	_
14	graft	graft	_	_	_	_	_	_	_
15	infiltration	infiltration	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	natural	natural	_	_	_	_	_	_	_
18	killer	killer	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	NK	NK	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	monocytes	monocyte	_	_	_	_	_	_	_
25	associated	associate	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	endothelial	endothelial	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	EC	EC	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	previously	previously	_	_	_	_	_	_	_
4	demonstrated	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	NK	nk	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	activate	activate	_	_	_	_	_	_	_
10	porcine	porcine	_	_	_	_	_	_	_
11	EC	EC	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	vitro	vitro	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	which	which	_	_	_	_	_	_	_
16	results	result	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	adhesion	adhesion	_	_	_	_	_	_	_
19	molecule	molecule	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	cytokine	cytokine	_	_	_	_	_	_	_
23	secretion	secretion	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	used	use	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	NK	NK	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	line	line	_	_	_	_	_	_	_
11	NK92	nk92	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	define	define	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	molecular	molecular	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	cellular	cellular	_	_	_	_	_	_	_
18	basis	basis	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	NK	NK	_	_	_	_	_	_	_
21	cell-mediated	cell-mediated	_	_	_	_	_	_	_
22	EC	EC	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	EC	EC	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	transfected	transfecte	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	either	either	_	_	_	_	_	_	_
8	reporter	reporter	_	_	_	_	_	_	_
9	constructs	construct	_	_	_	_	_	_	_
10	containing	contain	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	luciferase	luciferase	_	_	_	_	_	_	_
13	gene	gene	_	_	_	_	_	_	_
14	driven	drive	_	_	_	_	_	_	_
15	either	either	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	E-selectin	E-selectin	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	interleukin	interleukin	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	IL)-8	il)-8	_	_	_	_	_	_	_
22	promoters	promoter	_	_	_	_	_	_	_
23	or	or	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	synthetic	synthetic	_	_	_	_	_	_	_
26	NF-kappaB-dependent	nf-kappab-dependent	_	_	_	_	_	_	_
27	promoter	promoter	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	dominant-negative	dominant-negative	_	_	_	_	_	_	_
6	mutant	mutant	_	_	_	_	_	_	_
7	tumor	tumor	_	_	_	_	_	_	_
8	necrosis	necrosis	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	I	i	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	TNFRI	TNFRI	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	vector	vector	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	co-transfected	co-transfecte	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	inhibition	inhibition	_	_	_	_	_	_	_
21	studies	study	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Forty-eight	forty-eight	_	_	_	_	_	_	_
2	hours	hour	_	_	_	_	_	_	_
3	after	after	_	_	_	_	_	_	_
4	transfection	transfection	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	EC	EC	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	stimulated	stimulate	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	NK	NK	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	NK	NK	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	membrane	membrane	_	_	_	_	_	_	_
16	extracts	extract	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	7	7	_	_	_	_	_	_	_
19	hr	hr	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	was	be	_	_	_	_	_	_	_
23	measured	measure	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	luciferase	luciferase	_	_	_	_	_	_	_
27	assay	assay	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Co-culture	Co-culture	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NK	NK	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	transfected	transfecte	_	_	_	_	_	_	_
9	EC	EC	_	_	_	_	_	_	_
10	enhanced	enhance	_	_	_	_	_	_	_
11	E-selectin	E-selectin	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	IL-8	il-8	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	NF-kappaB-dependent	nf-kappab-dependent	_	_	_	_	_	_	_
17	promoter	promoter	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	NK	NK	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	membrane	membrane	_	_	_	_	_	_	_
4	extracts	extract	_	_	_	_	_	_	_
5	retained	retain	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	capacity	capacity	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	activate	activate	_	_	_	_	_	_	_
10	EC	EC	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	induced	induce	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	translocation	translocation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	p50	p50	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	p65	p65	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Western	Western	_	_	_	_	_	_	_
2	blotting	blotting	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NK	NK	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	membrane	membrane	_	_	_	_	_	_	_
8	extracts	extract	_	_	_	_	_	_	_
9	detected	detect	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	presence	presence	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	Lymphotoxin-alpha	Lymphotoxin-alpha	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	LTalpha	LTalpha	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	but	but	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	tumor	tumor	_	_	_	_	_	_	_
20	necrosis	necrosis	_	_	_	_	_	_	_
21	factor-alpha	factor-alpha	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	LTalpha	LTalpha	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	secreted	secrete	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	NK:EC	NK:EC	_	_	_	_	_	_	_
8	co-cultures	co-culture	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	Co-transfection	co-transfection	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	dominant-negative	dominant-negative	_	_	_	_	_	_	_
4	mutant	mutant	_	_	_	_	_	_	_
5	TNFRI	TNFRI	_	_	_	_	_	_	_
6	inhibited	inhibit	_	_	_	_	_	_	_
7	EC	EC	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	NK	NK	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	membrane	membrane	_	_	_	_	_	_	_
13	extracts	extract	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	NK	NK	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	80	80	_	_	_	_	_	_	_
20	%	%	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	47	47	_	_	_	_	_	_	_
23	%	%	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	respectively	respectively	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	same	same	_	_	_	_	_	_	_
3	pattern	pattern	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	inhibition	inhibition	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	observed	observe	_	_	_	_	_	_	_
8	using	use	_	_	_	_	_	_	_
9	anti-human	anti-human	_	_	_	_	_	_	_
10	LT	lt	_	_	_	_	_	_	_
11	sera	serum	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Human	human	_	_	_	_	_	_	_
4	NK	NK	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	membrane-bound	membrane-bound	_	_	_	_	_	_	_
7	LT	lt	_	_	_	_	_	_	_
8	signals	signal	_	_	_	_	_	_	_
9	across	across	_	_	_	_	_	_	_
10	species	specie	_	_	_	_	_	_	_
11	via	via	_	_	_	_	_	_	_
12	TNFRI	TNFRI	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	leading	lead	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	nuclear	nuclear	_	_	_	_	_	_	_
18	translocation	translocation	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	E-selectin	E-selectin	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	IL-8	IL-8	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	which	which	_	_	_	_	_	_	_
27	results	result	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	EC	EC	_	_	_	_	_	_	_
30	activation	activation	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	discrepancy	discrepancy	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	degree	degree	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	inhibition	inhibition	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	membrane	membrane	_	_	_	_	_	_	_
10	extracts	extract	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	NK	nk	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	mutant	mutant	_	_	_	_	_	_	_
16	TNFRI	TNFRI	_	_	_	_	_	_	_
17	suggests	suggest	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	additional	additional	_	_	_	_	_	_	_
20	pathways	pathway	_	_	_	_	_	_	_
21	are	be	_	_	_	_	_	_	_
22	utilized	utilize	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	NK	NK	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	activate	activate	_	_	_	_	_	_	_
28	EC	EC	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

